CPRX logo

Catalyst Pharmaceuticals, Inc. (CPRX)

Profile

Full Name

Catalyst Pharmaceuticals, Inc.

Ticker

NASDAQ: CPRX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

November 8, 2006

Indexes

Not included

Website

https://catalystpharma.com

Employees

181

Key Details

Price

$20.00(-0.40%)

Market cap

$2.45B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$491.73M(+23.49% YoY)

Annual EPS

$1.31(+107.94% YoY)

PE ratio

12.12

Next earnings date

Nov 5, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $20.00
    CPRX price is $20.00

    30-Day Relative Volume

    0.94
    CPRX 30-day relative volume is 0.94

    Price Performance

    Price Today change

    -0.4%
    CPRX price is down -0.4% today

    Price YTD change

    -4.17%
    CPRX price is down -4.17% since January 1st

    Price 1-year change

    +1.78%
    CPRX price is up +1.78% year-on-year

    Price 3-year change

    +35.41%
    CPRX price is up +35.41% over the past 3 years

    Price Range

    Price All-time high

    $26.58
    CPRX price is currently -24.76% below its historical high of $26.58

    Price 3-year low

    $11.09
    CPRX price is currently +80.34% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $2.45B
    CPRX market capitalization is $2.45 billion

    Market cap 3-year change

    +61.18%
    CPRX market capitalization is up +61.18% over the past 3 years

    Market cap All-time high

    $3.21B
    CPRX market capitalization is currently -23.72% below its historical high of $3.21 billion

    Market cap sector rank

    82.87%
    CPRX market capitalization is higher than 82.87% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +3.12%
    CPRX shares outstanding is up +3.12% year-on-year

    Shares Outstanding 3-Year Change

    +19.03%
    CPRX shares outstanding is up +19.03% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.87
    CPRX beta is 0.87

    200-day SMA

    $22.30
    CPRX price is currently -10.33% below its 200-day simple moving average

    50-day SMA

    $20.81
    CPRX price is currently -3.89% below its 50-day simple moving average

    RSI

    44.04
    CPRX 14-day relative strength index is 44.04

    Volume

    0.94
    CPRX 30-day relative volume is 0.94

    ATR

    $0.73
    CPRX average true range is $0.73

    10-day Historical Volatility

    30.98%
    CPRX 10-day historical volatility is 30.98%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $491.73M
    CPRX annual revenue is $491.73 million

    Revenue Analysts estimate

    $561.71M
    CPRX annual revenue is currently -12.46% lower than the consensus analysts' forecast

    Revenue 1-year change

    +23.49%
    CPRX annual revenue is up +23.49% year-on-year

    Revenue Sector rank

    81.28%
    CPRX annual revenue is higher than 81.28% of companies in Healthcare sector

    EPS

    EPS

    $1.31
    CPRX annual earnings per share is $1.31

    EPS Analysts estimate

    $2.34
    CPRX annual earnings per share is currently -44.11% lower than the consensus analysts' forecast

    EPS 1-year change

    +107.94%
    CPRX annual earnings per share is up +107.94% year-on-year

    EPS Sector rank

    90.08%
    CPRX annual earnings per share is higher than 90.08% of companies in Healthcare sector

    Profit

    Gross profit

    $385.51M
    CPRX annual gross profit is $385.51 million

    Gross margin

    78.40%
    CPRX annual gross profit margin is 78.40%

    Operating profit

    $195.12M
    CPRX annual operating income is $195.12 million

    Operating margin

    39.68%
    CPRX annual operating profit margin is 39.68%

    Net income

    $163.89M
    CPRX annual net profit is $163.89 million

    Net margin

    33.33%
    CPRX annual net profit margin is 33.33%

    Expenses

    Total expenses

    $327.85M
    CPRX annual total expenses is $327.85 million

    Operating expenses

    $190.39M
    CPRX annual total operating expenses is $190.39 million

    Cost of goods sold

    $106.22M
    CPRX annual cost of goods sold is $106.22 million

    Selling, general & administrative expenses

    $0.00
    CPRX annual SGA is $0.00

    Depreciation and amortization

    $38.05M
    CPRX annual depreciation & amortization is $38.05 million

    Interest expense

    $0.00
    CPRX annual interest expense is $0.00

    Income tax

    $52.37M
    CPRX annual income tax is $52.37 million

    EBIT & EBITDA

    EBIT

    $195.12M
    CPRX annual earnings before interest & taxes is $195.12 million

    EBITDA

    $233.18M
    CPRX annual EBITDA is $233.18 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $854.49M
    CPRX annual total assets is $854.49 million

    Non current assets

    $227.80M
    CPRX annual long term assets is $227.80 million

    Current assets

    $623.61M
    CPRX annual total current assets is $623.61 million

    Cash and cash equivalents

    $517.55M
    CPRX annual cash & cash equivalents is $517.55 million

    Accounts receivable

    $65.48M
    CPRX annual accounts receivable is $65.48 million

    Inventory

    $19.54M
    CPRX annual inventory is $19.54 million

    Liabilities

    Total liabilities

    $126.86M
    CPRX annual total liabilities is $126.86 million

    Long term liabilities

    $3.39M
    CPRX annual total long term liabilities is $3.39 million

    Current liabilities

    $120.68M
    CPRX annual total current liabilities is $120.68 million

    Accounts payable

    $16.59M
    CPRX annual accounts payable is $16.59 million

    Debt

    Total debt

    $3.19M
    CPRX annual total debt is $3.19 million

    Total debt 1-year change

    -10.37%
    CPRX annual total debt is down -10.37% year-on-year

    Long term debt

    $2.79M
    CPRX annual long term debt is $2.79 million

    Short term debt

    $402.00K
    CPRX annual short term debt is $402.00 thousand

    Equity & Capital

    Shareholders equity

    $727.63M
    CPRX annual stockholders equity is $727.63 million

    Book value

    $727.63M
    CPRX annual book value is $727.63 million

    Retained earnings

    $285.16M
    CPRX annual retained earnings is $285.16 million

    Working capital

    $502.93M
    CPRX annual working capital is $502.93 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $239.81M
    CPRX annual cash flow from operations is $239.81 million

    Cash from operations 1-year change

    +67%
    CPRX annual cash flow from operations is up +67% year-on-year

    Cash from investing

    -$556.00K
    CPRX annual cash flow from investing activities is -$556.00 thousand

    Cash from investing 1-year change

    +99.81%
    CPRX annual cash flow from investing activities is up +99.81% year-on-year

    Cash from financing

    $140.66M
    CPRX annual cash flow from financing activities is $140.66 million

    Cash from financing 1-year change

    +1395.62%
    CPRX annual cash flow from financing activities is up +1395.62% year-on-year

    CAPEX

    CAPEX

    $556.00K
    CPRX annual capital expenditures is $556.00 thousand

    CAPEX 1-year change

    -99.72%
    CPRX annual capital expenditures is down -99.72% year-on-year

    Free Cash Flow

    Free cash flow

    $239.25M
    CPRX annual free cash flow is $239.25 million

    Free cash flow 1-year change

    +535.61%
    CPRX annual free cash flow is up +535.61% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    78.40%
    CPRX annual gross profit margin is 78.40%

    Operating margin

    39.68%
    CPRX annual operating profit margin is 39.68%

    Net margin

    33.33%
    CPRX annual net profit margin is 33.33%

    ROA & ROE

    ROA

    24.71%
    CPRX annual return on assets is 24.71%

    ROE

    29.38%
    CPRX annual return on equity is 29.38%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    12.12
    CPRX price to earnings ratio is 12.12

    PE ratio Sector rank

    18.4%
    CPRX price to earnings ratio is higher than 18.4% of companies in Healthcare sector

    PB Ratio

    PB ratio

    2.86
    CPRX price to book ratio is 2.86

    PB ratio Sector rank

    63.38%
    CPRX price to book ratio is higher than 63.38% of companies in Healthcare sector

    PS Ratio

    PS ratio

    4.38
    CPRX price to sales ratio is 4.38

    PS ratio Sector rank

    54.59%
    CPRX price to sales ratio is higher than 54.59% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $1.80B
    CPRX enterprise value is $1.80 billion

    Enterprise value Sector rank

    79.39%
    CPRX enterprise value is higher than 79.39% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    6.39
    CPRX EV/EBITDA is 6.39

    EV/EBITDA Sector rank

    78%
    CPRX EV/EBITDA is higher than 78% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    5.17
    CPRX annual current ratio is 5.17

    Quick ratio

    5.01
    CPRX annual quick ratio is 5.01

    Leverage

    Debt to equity

    0.00
    CPRX annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    CPRX annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    6
    CPRX piotroski f-score is 6

    Altman Z-Score

    14.08
    CPRX altman z-score is 14.08

    Analyst ratings

    Recent major analysts updates

    Mar 3, 25 Baird
    Outperform
    Feb 28, 25 HC Wainwright & Co.
    Buy
    Feb 27, 25 Stephens & Co.
    Overweight
    Feb 4, 25 Baird
    Outperform
    Jan 10, 25 HC Wainwright & Co.
    Buy
    Jan 9, 25 B of A Securities
    Buy
    Nov 18, 24 Stephens & Co.
    Overweight
    Nov 11, 24 Truist Securities
    Buy
    Nov 8, 24 HC Wainwright & Co.
    Buy
    Aug 12, 24 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with CPRX included

    Growing Shares Outstanding
    Mid cap stocks
    US stocks
    High Piotroski score stocks
    Stocks below SMA 200
    Most recommended stocks
    Best performing stocks last 5 years
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    • What is the ticker symbol for Catalyst Pharmaceuticals, Inc.?
    • Does Catalyst Pharmaceuticals, Inc. pay dividends?
    • What sector is Catalyst Pharmaceuticals, Inc. in?
    • What industry is Catalyst Pharmaceuticals, Inc. in?
    • What country is Catalyst Pharmaceuticals, Inc. based in?
    • When did Catalyst Pharmaceuticals, Inc. go public?
    • Is Catalyst Pharmaceuticals, Inc. in the S&P 500?
    • Is Catalyst Pharmaceuticals, Inc. in the NASDAQ 100?
    • Is Catalyst Pharmaceuticals, Inc. in the Dow Jones?
    • When was Catalyst Pharmaceuticals, Inc.'s last earnings report?
    • When does Catalyst Pharmaceuticals, Inc. report earnings?

    What is the ticker symbol for Catalyst Pharmaceuticals, Inc.?

    The ticker symbol for Catalyst Pharmaceuticals, Inc. is NASDAQ:CPRX

    Does Catalyst Pharmaceuticals, Inc. pay dividends?

    No, Catalyst Pharmaceuticals, Inc. does not pay dividends

    What sector is Catalyst Pharmaceuticals, Inc. in?

    Catalyst Pharmaceuticals, Inc. is in the Healthcare sector

    What industry is Catalyst Pharmaceuticals, Inc. in?

    Catalyst Pharmaceuticals, Inc. is in the Biotechnology industry

    What country is Catalyst Pharmaceuticals, Inc. based in?

    Catalyst Pharmaceuticals, Inc. is headquartered in United States

    When did Catalyst Pharmaceuticals, Inc. go public?

    Catalyst Pharmaceuticals, Inc.'s initial public offering (IPO) was on November 8, 2006

    Is Catalyst Pharmaceuticals, Inc. in the S&P 500?

    No, Catalyst Pharmaceuticals, Inc. is not included in the S&P 500 index

    Is Catalyst Pharmaceuticals, Inc. in the NASDAQ 100?

    No, Catalyst Pharmaceuticals, Inc. is not included in the NASDAQ 100 index

    Is Catalyst Pharmaceuticals, Inc. in the Dow Jones?

    No, Catalyst Pharmaceuticals, Inc. is not included in the Dow Jones index

    When was Catalyst Pharmaceuticals, Inc.'s last earnings report?

    Catalyst Pharmaceuticals, Inc.'s most recent earnings report was on August 6, 2025

    When does Catalyst Pharmaceuticals, Inc. report earnings?

    The next expected earnings date for Catalyst Pharmaceuticals, Inc. is November 5, 2025
    On this page